Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons

Alvarez D, Dieterich D, Brau N, Moores L, Ball L, Sulkowski MS. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J Viral Hepat. 2006;13:683-689.

Publication Type:

Journal Article

Authors:

Alvarez, D.; D. Dieterich; Brau, N.; Moores, L.; Ball, L.; M S Sulkowski

Source:

J Viral Hepat, Volume 13, p.683-689 (2006)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top